[The role of autologous hemopoietic stem cell transplantation in T-cell lymphoma. Hungarian data]. / Autológ haemopoeticus ossejt-transzplantáció szerepe T-sejtes lymphomában. Magyar adatok.
Orv Hetil
; 158(41): 1615-1619, 2017 Oct.
Article
em Hu
| MEDLINE
| ID: mdl-29025289
ABSTRACT
T-cell lymphoma is a poor prognostic hematological malignancy. The generally used - not sufficiently effective - induction chemotherapy should be improved with consolidative autologous hemopoetic stem cell transplantation. The authors describe the role, place and effectiveness of transplantation in this disorder. One hundred thirty three autologous stem cell transplantations were performed in the last 22 years in Hungary. Detailed results are available from the last 6 years. In this period 43 transplantations were carried out in 4 Hungarian centers. Carmustine-etoposide-cytosine arabinoside-melphalan (BEAM) conditioning regimen was used in 95%. The transplantation was done mainly in complete remission (84%), 1 year after transplantation 65% of patients were still in complete remission. Eleven patients died, 82% of them have progressive disease. Brentuximab vedotin has already proved the effectiveness, several other chemoterapeutics, monoclonal antibodies, kinase inhibitors are under investigation. In certain cases allogeneic stem cell transplantation has real indication among therapeutic options. Orv Hetil. 2017; 158(41) 1615-1619.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Linfoma de Células T
/
Imunoconjugados
/
Transplante de Células-Tronco Hematopoéticas
Limite:
Humans
País/Região como assunto:
Europa
Idioma:
Hu
Ano de publicação:
2017
Tipo de documento:
Article